Radiology Registry on Pancreatic Malignancies
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Radiology evaluations and interventions.
- Who it may be relevant to
- Registry conditions: Pancreatic Cancer, Pancreas Neoplasm, Pancreas Disease, Pancreas Cyst. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Italy
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The purpose of this study is to collect all radiological data which evaluated with clinical data may help assess malignancy and prognosis of pancreatic disease.This registry aims to collect retrospective data from 2014 and prospective data until 2027 with a maximum follow-up of 3 years per patient.
Detailed description
Single center, observational (retrospective and prospective) will collect all available parameters to assess the clinical outcome of the patients (progression free survival (PFS), overall survival (OS), local progression free survival LTPFS), response to treatment) with pancreatic neoplasms presenting to San Raffaele. Patient assignment to a given diagnostic and/or therapeutic procedure is not related to random assignment methods but is part of the ordinary therapeutic strategy planned for each patient on an individual basis and after multidisciplinary discussion.
Interventions
- Other Radiology evaluations and interventions
Diagnostic and interventional radiology procedures
Primary outcome measures
- Progression- free survival [Time frame: From date of intervention until the date of first documented progression, up to a maximum of 3 years]
- Local progression free survival [Time frame: From date of intervention until the date of first documented local progression assessed up to a maximum of 3 years]
Secondary outcome measures (1)
- Overall Survival [Time frame: From date of treatment until the date of death from any cause assessed up to 3 years]
Eligibility criteria
Inclusion criteria
- ≥18 years of age
- Patients with suspect (planned for investigation) or diagnosed pancreatic cancer at any stage.
- able and willing to sign informed consent
Exclusion criteria
- Patients with non-primary pancreatic disease
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Italy · 1 center
- Department of Radiology, IRCCS Ospedale San Raffaele — Milan
Identifiers
NCT: NCT05714111 · RadonPams